Skip to main content

Table 5 Standardized Incidence Ratios (SIRs) for overall cancer and the 10 leading causes of cancer.

From: Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

INCIDENCE

ICD-10 Code

Expected incidence

Observed Incidence

SIR

L95%CI

U95%CI

Cancers Overall

C00:C99 excl. C56, C57.0, C44

4610

4131

88.1%

85.4%

90.9%

Lung Cancer

C33:C34

582

328

56.2%

50.2%

62.6%

Breast Cancer

C50

1715

1748

99.8%

95.1%

104.6%

Colorectal Cancer

C18:C21

511

471

91.1%

83.1%

99.8%

Pancreatic Cancer

C25

122

84

68.1%

54.3%

84.4%

Oesophagus Cancer

C15

75

54

71.6%

53.8%

93.4%

Stomach Cancer

C16

65

56

85.0%

64.0%

110.6%

N-H Lymphoma

C82:C85, C96

168

175

103.6%

88.8%

120.2%

Leukaemia

C91:C95

75

58

77.7%

59.0%

100.4%

Uterus Cancer

C54:C55

318

293

91.1%

80.9%

102.2%

Bladder Cancer

C67

77

64

79.5%

60.8%

102.1%

  1. Ovarian (C56)/tubal cancer (C57.0) and other malignant neoplasm of skin (C44) have been excluded. Average time in trial at censoring (1st June 2006) = 2.58 yrs/woman.